SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending as President Trump's threats of new tariffs on European nations over Greenland escalate geopolitical tensions, leading to a risk-off market sentiment. The community is divided, with some anticipating a significant market pullback, while others view it as a 'buy the dip' opportunity, also noting a Japan-led bond sell-off as a contributing factor. This environment is fueling discussions about broader market volatility and a flight to safe-haven assets.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following Saudi Arabia's approval of its Anktiva-based Bioshield protocol for non-small cell lung cancer and broader cancer treatment, alongside ongoing discussions with the FDA for papillary bladder cancer. The community is passionately discussing the potential for a significant short squeeze, viewing the company as a disruptive force in oncology while expressing strong frustration with perceived FDA delays.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is actively trending amid escalating US-EU trade tensions driven by President Trump's tariff threats over Greenland, sparking a widespread market sell-off and global risk-off sentiment. The investment community is sharply divided between those anticipating a deeper correction for technology and growth stocks and fervent "buy the dip" proponents. Immediate market focus remains on an upcoming Supreme Court ruling regarding tariff authority and a heavy week of earnings reports, amplifying uncertainty.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is generating significant buzz following a substantial upward revision to its future revenue outlook and a surging order backlog, further bolstered by a recent large capital raise. The community is actively discussing its promising potential as a rapidly expanding defense and autonomy platform, especially amidst ongoing negotiations for key acquisitions in the critical drone technology sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst intense debate spurred by former President Trump's controversial push for tariffs against European nations, reportedly tied to his interest in Greenland and past grievances. This situation has ignited polarized community discussions concerning potential trade wars and geopolitical repercussions, with many weighing economic stability against his "America First" agenda.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is trending due to a significant surge in natural gas futures, driven by widespread forecasts for severe arctic cold fronts across the US, intensifying heating demand expectations. The community is actively debating the potential for a powerful short squeeze amidst historically high short interest, while also acknowledging the inherent volatility and decay of leveraged natural gas ETFs like $BOIL, often referred to as a "widow maker". Discussions highlight the impact of this weather event on depleting storage levels, yet some remain cautious, pointing to broader warm winter trends and structural factors like contango, questioning the rally's sustainability.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is a major talking point following its J.P. Morgan conference appearance, where investors are eagerly seeking clarity on its strategy for advancing the Matrix-M adjuvant technology and securing new collaborations. Community sentiment is sharply focused on management's pace in realizing pipeline potential, including a recent Pfizer agreement and ongoing Sanofi ventures, with an activist investor's growing stake and significant short interest adding to the intense market watch.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is actively trending amid recent allegations of money laundering and illicit financial ties, triggering a sharp sell-off across the stock. Despite this, community sentiment is divided, with many dismissing the claims as a coordinated short attack ahead of strong earnings, while others are seizing the opportunity to buy into the fundamentally strong AI-powered ad platform.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending after announcing positive data from its placebo-controlled Phase 1 clinical trial of soquelitinib for atopic dermatitis, showing strong efficacy. The community is actively discussing the oral ITK inhibitor's potential in a large market, with many anticipating significant revaluation and partnership opportunities for its novel mechanism of action.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors react to a significant patent extension for its key products until 2041, coupled with a bullish preliminary business update accelerating IBSRELA's path to $1 billion in revenue by 2029 and multiple analyst price target upgrades. The community is buzzing with renewed acquisition speculation and optimism over the company's long-term value, despite ongoing discussions about short-term price fluctuations attributed to market dynamics. This confluence of positive developments has many viewing Ardelyx as a significantly undervalued biotech with strong commercial execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Abercrombie &amp; Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection.</li><li>The company narrowed its earnings per share (EPS) outlook to a range of $10.30 and $10.40 from the previous range of $10.20 to $10.50.&nbsp;</li><li>Capital expenditures are estimated at around $245 million, up from $225 million previously.</li></ul>Abercrombie &amp; Fitch Co. (ANF) on Monday trimmed its outlook for annual net sales growth, a move that rattled investors and pushed the retailer’s shares sharply lower.&nbsp;The apparel retailer released its outlook for the fourth quarter (Q4) and the full fiscal year 2025.&nbsp;<h2 class="st-heading-2">Guidance Update And Market Reaction</h2>Abercrombie &amp; Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection that called for growth in the 6% to 7% range. The company expects an operating margin of approximately 13% and an effective tax rate near 30%.The company narrowed its earnings per share (EPS) outlook to a range of $10.30 and $10.40 from the previous range of $10.20 to $10.50. The analysts' consensus estimate according to Fiscal AI data is $9.82.&nbsp;Retailers across the sector have faced shifting consumer spending patterns, uneven demand for discretionary goods, and heightened sensitivity to pricing as inflation and interest rates pressure household budgets.<a href="https://stocktwits.com/symbol/ANF">Abercrombie &amp; Fitch stock&nbsp;</a>tumbled by over 16% lower on Monday mid-morning. However, on Stocktwits, retail sentiment around the stock shifted to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_12_121129_png_f9241b1f1b.webp" alt="ANF’s Sentiment Meter and Message Volume as of 11:30 a.m. ET on Jan. 12, 2026 | Source: Stocktwits" width="929" height="97"><figcaption>ANF’s Sentiment Meter and Message Volume as of 11:30 a.m. ET on Jan. 12, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Capital Expenditure Jumps&nbsp;</h2>Capital expenditures are estimated at around $245 million, up from $225 million previously. Abercrombie &amp; Fitch also plans roughly 40 net store openings, along with 40 remodels and right-sizing efforts.&nbsp;For Q4, the retailer anticipates net sales growth of around 5%, with operating margins at roughly 14%.&nbsp;Earnings per diluted share are expected between $3.50 and $3.60 with a consensus estimate of $3.60, according to Fiscal AI data. Share repurchases for the quarter are projected at approximately $100 million.&nbsp;ANF stock has declined by over 23% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-to-use-google-s-gemini-ai-for-siri-overhaul-report/cmUa2VCR4E0">Apple To Use Google’s Gemini AI For Siri Overhaul: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a hand holds a smartphone displaying the logo of Abercrombie & Fitch Co. 

Why Did Abercrombie & Fitch Stock Plunge Over 16% Today? 

Abercrombie & Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection that called for growth in the 6% to 7% range.

Equity

Abercrombie & Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection that called for growth in the 6% to 7% range.


Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now?

Should You Invest in the State Street SPDR S&P Retail ETF (XRT)?

3 Undervalued ETFs to Buy Before 2026

Worried about high valuations? KBE, XRT, and XPH with low P/Es and fresh momentum are three undervalued ETFs to consider as 2026 approaches.

<ul class="summary-bullets"><li>Tapestry stock has gained about 23% since its earnings report on Nov. 6.</li><li>After failing a few times earlier in the year, TPR could hit a new high.</li><li>The momentum is driven by the company’s strong revival, led by its Coach handbags brand and marketing strategy.</li></ul>Among the few retail brands to maintain an upward trajectory in the tariff era, Tapestry ranks among the top echelons.&nbsp;The handbags and accessories company has swung back to topline growth in recent quarters, powered by its flagship Coach brand — and its stock is now nearing a fresh record.Tapestry opened at $116 on Tuesday and could breach its previous high of $118.56 from Oct. 15 (intraday high), marking a clean breakout&nbsp;and possibly barrelling toward a new record high. TPR has logged three major rallies this year — during June-July, again in August–September, and now the latest surge, with shares up roughly 23% since its fiscal first-quarter earnings on Nov. 6.<figure class="image"><img style="aspect-ratio:1400/1100;" src="https://news.stocktwits-cdn.com/koyfin_20251209_073926537_png_7d7621c6db.webp" alt="koyfin_20251209_073926537.png" width="1400" height="1100"></figure><h2 class="st-heading-2">The Coach Pump</h2>Powering the performance is Coach, a brand of handbags and leather goods, which contributes about three-quarters of the company’s topline.&nbsp;Tapestry has said that new Coach products, including the “Tabby” line and the “New York” collection, and its marketing strategy, which positions the brand as “affordable luxury,” are driving sales. Coach also got fewer discounts, boosting average revenue per product sold, and is becoming increasingly popular with younger customers, the company said.Sales at Tapestry’s other two brands – Kate Spade and Stuart Weitzman – have been shrinking.<figure class="image"><img style="aspect-ratio:1600/1133;" src="https://news.stocktwits-cdn.com/Coach_revenue_jpg_453949cc4f.webp" alt="Coach_revenue.jpg" width="1600" height="1133"><figcaption>&nbsp;</figcaption></figure><figure class="image"><img style="aspect-ratio:1600/1133;" src="https://news.stocktwits-cdn.com/Tapestry_overall_revenue_1_jpg_ef18c4667b.webp" alt="Tapestry_overall_revenue (1).jpg" width="1600" height="1133"></figure><h2 class="st-heading-2">Gen Z Strategy</h2>At its investor day event in September, Tapestry unveiled an “Amplify Growth Strategy” with four pillars: building emotional connections with consumers (especially Gen Z), driving fashion innovation, accelerating global growth, and focusing on staff.Early signs have already emerged: in Q1, Tapestry reported record revenue of $1.70 billion, up 13%, including 22% growth in Coach sales. The company said it gained 2.2 million new customers in the quarter, and about 35% of them were Gen Z.<h2 class="st-heading-2">Retail and Analyst View</h2>With those numbers, especially after the company had to significantly realign after its merger with Capri Holdings fell through late last year, it's easy to win analyst backing.Currently, 15 of the 20 analysts covering the TPR have a ‘Buy’ or higher rating, while four rate it ‘Hold,’ and one rates it ‘Sell,’ according to Koyfin. Their average price target of $121.44 implies a mere 3.6% upside from the stock’s last close.On Stocktwits, the retail sentiment reading for&nbsp;<a href="https://stocktwits.com/symbol/TPR">TPR</a> shifted to ‘Bullish’ as of early Tuesday, from ‘Neutral’ the previous day, with several users noticing the recent rally.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/china-probably-won-t-need-nvidia-for-long-beijing-s-homegrown-ai-chip-empire-is-rising-stealthily/cLIrvzgREZK">China Probably Won't Need Nvidia For Long — Beijing's Homegrown AI Chip Empire Is Rising Stealthily</a>

Tapestry, known for brands like Coach, Kate Spade, and Stuart Weitzman, and Capri, the parent company of Michael Kors, Versace, and Jimmy Choo, originally announced their merger in August 2023.

Tapestry Stock Eyes Fresh Record High As Coach-Fueled Rally Powers Ahead

Tapestry opened at $116 on Tuesday and could breach its previous high of $118.56 from Oct. 15.

Strong Start to Holiday Season Amid Strains Spotlight These Retail ETFs

Record holiday spending masks consumer strain, but strong retail earnings lift interest in ETFs XRT, RTH, IBUY and ONLN.

Shoppers wait in line to checkout at a Best Buy store in West Covina, California. (Photo by Gina Ferazzi/Los Angeles Times via Getty Images)

First, Amazon Came For Walmart’s Retail Crown — Now It’s Snatched Best Buy’s Electronics Throne As Well

Electronics is one of the largest consumer goods categories and a major draw for both physical retailers and e-commerce platforms.

Holiday crowds begin to gather in a shopping district at Rockefeller Center on the afternoon before Thanksgiving on November 26, 2025, in New York City. (Photo by Spencer Platt/Getty Images)

Fashion Might Be The Only Thing Saving Retail Right Now — Viral Ads And Bold Revamps Are Powering ANF, URBN, GAP Into Surprise Holiday Rallies

Fashion, which includes clothes, footwear, and accessories, is typically one of the first hit categories in a downturn.

ETFs Likely to Benefit from Thanksgiving Weekend Sales

Thanksgiving shopping is set to boost retail and tech ETFs. XRT, IBUY, ONLN, IPAY, BPAY and PSCD could be the biggest winners of the holiday spending boom.

Holiday Shopping Could Soar To A Record $1 Trillion This Year, With Online Spending Blasting To New Highs

E-commerce spending between Nov. 1 and Nov. 23 rose 7.5% to $79.7 billion, according to Adobe Analytics.

XRT
SPDR S&P Retail ETF

Feed

News

Sentiment

Fundamentals

Info

Latest XRT News

XRTSPDR S&P Retail ETF